This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WITH A REPORT OF SEVEN CASES

ALBERT LOUIS BROWN, M.D.; JANET PUGH, B.A.

Arch Ophthal. 1936;16(3):476-493.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The parenteral administration of various proteins for their nonspecific action on ocular inflammations is an accepted procedure. There have been many opinions expressed concerning the mode of action of this form of therapy. The consensus seems to emphasize a rise in the body temperature, which is considered to be well above the optimum for various organisms. Leukocytosis, which usually accompanies such therapy, is supposed to be beneficial and to indicate an increase in the general body defense. The other factors, such as an increase in the complement and antibody content of the blood, are grouped under the vague term "increased general resistance." Suffice it to say that the mechanism of the action of nonspecific therapy is not understood. So far as the eye is concerned, the rise in temperature could not benefit inflammations of the uveal tract by killing organisms, for the intra-ocular contents in a case of nonspecific . . . [Full Text PDF of this Article]

Author Affiliations
CINCINNATI

From the Children's Hospital Research Foundation.

Footnotes
Read before the Section on Ophthalmology at the Eighty-Seventh Annual Session of the American Medical Association, Kansas City, Mo., May 15, 1936.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?